Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients

Camilo G. Sotomayor*, Antonio W. Gomes-Neto, Marco van Londen, Rijk O. B. Gans, Ilja M. Nolte, Stefan P. Berger, Gerjan J. Navis, Ramon Rodrigo, Henri G. D. Leuvenink, Casper G. Schalkwijk, Stephan J. L. Bakker

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1512-1520
Number of pages9
JournalClinical journal of the American Society of Nephrology
Volume14
Issue number10
DOIs
Publication statusPublished - 7 Oct 2019

Keywords

  • advanced glycation end-product
  • cardiovascular mortality
  • renal transplantation
  • oxidative stress
  • endothelial dysfunction
  • humans
  • area under curve
  • ROC curve
  • Glycation End Products
  • Advanced
  • confidence interval
  • Transplantation
  • Homologous
  • kidney transplantation
  • allografts
  • kidney diseases
  • kidney disease
  • fibrosis
  • biopsy
  • kidney biopsy
  • magnetic resonance imaging
  • hypoxia
  • glomerulonephritis
  • oxygen
  • cardiovascular disease
  • cohort studies
  • END-PRODUCTS
  • N-EPSILON-(CARBOXYMETHYL) LYSINE
  • ENDOTHELIAL DYSFUNCTION
  • PREDICTS MORTALITY
  • OXIDANT STRESS
  • ACCUMULATION
  • INFLAMMATION
  • CREATININE
  • SURVIVAL
  • DISEASE

Cite this

Sotomayor, C. G., Gomes-Neto, A. W., van Londen, M., Gans, R. O. B., Nolte, I. M., Berger, S. P., Navis, G. J., Rodrigo, R., Leuvenink, H. G. D., Schalkwijk, C. G., & Bakker, S. J. L. (2019). Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients. Clinical journal of the American Society of Nephrology, 14(10), 1512-1520. https://doi.org/10.2215/CJN.00540119